We built a nighttime recovery company. The distinction matters more than anything else we could tell you.
Sleep is not passive. While you sleep, your body releases growth hormone, synthesizes collagen, consolidates memory, repairs damaged tissue, and clears metabolic waste from the brain. N3 slow-wave sleep — the deepest phase — is where the majority of this recovery occurs. Most adults spend less than 15% of their night there.
NOCTURNIX was built around a single insight: the compounds that support this recovery process are already known. The research exists. The problem has always been delivery. Most oral supplements are degraded before they ever reach the tissue they were designed to support. We fixed the delivery.
Oral bioavailability — the percentage of an ingested compound that actually enters systemic circulation — averages between 15 and 30 percent for most supplements. Your liver intercepts the rest before it ever gets the chance to work. This is called first-pass metabolism, and it is not a minor inconvenience. It is the reason most supplements perform far below their potential.
The industry response has been to increase doses. If 30 percent reaches circulation, take three times the amount. It is a workaround. It is not a solution.
The human body has one surface that bypasses this problem entirely. The olfactory epithelium — a thin layer of specialized tissue inside the nasal cavity — sits adjacent to the bloodstream in a way no other external surface does. Compounds absorbed here do not pass through the digestive system. They do not encounter the liver. They enter systemic circulation directly, within minutes, at a fraction of the degradation that oral delivery causes.
Transmucosal nasal delivery has been used in pharmaceutical medicine for decades — emergency medications, hormone therapies, neurological compounds — precisely because of its speed and bioavailability. NOCTURNIX is the first brand built specifically around this mechanism for nighttime recovery.
NOCTURNIX formulas achieve bioavailability exceeding 94 percent. NOCTURNA delivers magnesium, L-theanine, and GABA transmucosally — compounds that either cannot cross the blood-brain barrier orally, or are largely destroyed before they reach circulation. AEGIS delivers GHK-Cu, a copper peptide with well-documented tissue repair and collagen synthesis activity, at clinical concentration directly into the bloodstream. Both formulas are designed to work during the hours your body is already running its repair protocols.
NOCTURNA initiates and extends N3 slow-wave sleep — the phase where growth hormone releases and cognitive consolidation occurs. AEGIS supports the cellular repair that happens during that same window. Together they form a complete overnight recovery protocol: one formula for the sleep architecture, one for the cellular environment in which that recovery takes place.
You take both before sleep. While you sleep, the compounds work. You wake up recovered.
NOCTURNIX does not produce a large catalog. We produce a small number of formulas that we believe are the most effective versions of what they are designed to do. Each formula ships with a Certificate of Analysis from an independent third-party laboratory, testing for potency, purity, heavy metals, and microbial contamination. Every batch. Without exception.
We do not use proprietary blends. We do not use marketing doses. Every compound is listed at its actual concentration per serving, and every concentration is clinically meaningful at that dose delivered transmucosally.
Precision is not a feature of NOCTURNIX formulas. It is the only standard we operate under.
These statements have not been evaluated by the Food and Drug Administration. NOCTURNIX products are not intended to diagnose, treat, cure, or prevent any disease.